Gene · 3921
NIH grants1,143
NIH grants whose papers are about the gene, through NIH's grant-paper links.
561 to 580 of 1,143
Download this page as JSON| Grant | Title | RPSA papers | Newest fiscal year |
|---|---|---|---|
| R25HG007630 | The Flybase Diversity Action Plan | 1 | 2018 |
| R33HL120783 | Cardiac phenotyping of CHD candidate genes in Xenopus | 1 | 2018 |
| R33HL120791 | Identifying Genome-wide Association Study-Nominated Regulators of Erythropoiesis | 1 | 2018 |
| R41ES028991 | Embryonic stem cell high throughput screen accurately reports toxic stress | 1 | 2018 |
| R43EY029210 | Development of a first-in-class, potent and safe, small synthetic anti-angiogenic peptide for treatment of retinopathy of prematurity | 1 | 2018 |
| R56AG058854 | ENIGMA World Aging Center | 1 | 2018 |
| R56AG061163 | Omic analyses for stratifying Alzheimer's subtypes and identifying novel drug targets | 1 | 2018 |
| RF1AG052324 | Di-Leu-enabled multiplexed quantitation for biomarker discovery and validation in Alzheimer's disease | 1 | 2018 |
| S10OD023696 | Hybrid GPU/CPU Computing Resource to Support Connectomic and Genomics | 1 | 2018 |
| S10OD024999 | Thermo Lumos Tribrid High-Resolution Accurate-Mass Tandem Mass Spectrometer | 1 | 2018 |
| S10OD025040 | An Upright Multiphoton Microscopy System to Support the Biomedical Sciences | 1 | 2018 |
| S10OD025170 | NovaSeq Shared Instrumentation Grant for Wayne State University | 1 | 2018 |
| T32GM008646 | Training Program in Molecular, Cell, and Developmental Biology | 1 | 2018 |
| U01AG046161 | Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease | 1 | 2018 |
| U01DK061010 | Continuation of UCSF as a Clinical Center for TrialNet | 1 | 2018 |
| U01DK061034 | Northwest Clinical Center for Type 1 Diabetes - TrialNet | 1 | 2018 |
| U01DK061042 | TrialNet at Stanford University | 1 | 2018 |
| U01DK061058 | Prediction and Prevention of Type 1 Diabetes (TrialNet) | 1 | 2018 |
| U01DK085461 | TrialNet: University of Florida Clinical Center and Network | 1 | 2018 |
| U01DK085465 | Vanderbilt University: Clinical Center Application, Type 1 Diabetes TrialNet | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3921/grants?page=29